High throughput screening of particle conditioning operations: II. Evaluation of scale-up heuristics with prokaryotically expressed polysaccharide vaccines
ABSTRACT Multivalent polysaccharide conjugate vaccines are typically comprised of several different polysaccharides produced with distinct and complex production processes. Particle conditioning steps, such as precipitation and flocculation, may be used to aid the recovery and purification of such m...
Gespeichert in:
Veröffentlicht in: | Biotechnology and bioengineering 2015-08, Vol.112 (8), p.1568-1582 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1582 |
---|---|
container_issue | 8 |
container_start_page | 1568 |
container_title | Biotechnology and bioengineering |
container_volume | 112 |
creator | Noyes, Aaron Huffman, Ben Berrill, Alex Merchant, Nick Godavarti, Ranga Titchener-Hooker, Nigel Coffman, Jonathan Sunasara, Khurram Mukhopadhyay, Tarit |
description | ABSTRACT
Multivalent polysaccharide conjugate vaccines are typically comprised of several different polysaccharides produced with distinct and complex production processes. Particle conditioning steps, such as precipitation and flocculation, may be used to aid the recovery and purification of such microbial vaccine products. An ultra scale‐down approach to purify vaccine polysaccharides at the micro‐scale would greatly enhance productivity, robustness, and speed the development of novel conjugate vaccines. In part one of this series, we described a modular and high throughput approach to develop particle conditioning processes (HTPC) for biologicals that combines flocculation, solids removal, and streamlined analytics. In this second part of the series, we applied HTPC to industrially relevant feedstreams comprised of capsular polysaccharides (CPS) from several bacterial species. The scalability of HTPC was evaluated between 0.8 mL and 13 L scales, with several different scaling methodologies examined. Clarification, polysaccharide yield, impurity clearance, and product quality achieved with HTPC were reproducible and comparable with larger scales. Particle sizing was the response with greatest sensitivity to differences in processing scale and enabled the identification of useful scaling rules. Scaling with constant impeller tip speed or power per volume in the impeller swept zone offered the most accurate scale up, with evidence that time integration of these values provided the optimal basis for scaling. The capability to develop a process at the micro‐scale combined with evidence‐based scaling metrics provide a significant advance for purification process development of vaccine processes. The USD system offers similar opportunities for HTPC of proteins and other complex biological molecules. Biotechnol. Bioeng. 2015;112: 1568–1582. © 2015 Wiley Periodicals, Inc.
The High Throughput Particle Conditioning tool previously described in Part 1 of this series is tested on several prokaryotic polysaccharide vaccines streams of industrial relevance. The scalability of this method was evaluated between the 800 microliter and the 13 liter scales. Clarification, yield, impurity clearance and product quality were all evaluated as different scaling methods were evaluated to ascertain which provided the best matched results. This work represents a significant advance in high throughput development of vaccine processes. |
doi_str_mv | 10.1002/bit.25580 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1709763676</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3735117111</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4940-9cac6e363079d6edfcfd54429f4c040a3a4c2b5df77b964cd70d827f7a5fcb213</originalsourceid><addsrcrecordid>eNqNkk1v1DAQhiMEotvCgT-ALHGBQ7aO7dgxN1j6sVL5koo4Wo4z2bj1JsFO2u5v6Z_FadoekBAcLHvGz_tqPJ4keZXhZYYxOSztsCR5XuAnySLDUqSYSPw0WWCMeUpzSfaS_RAuYigKzp8neyQXRGSSLZLbU7tp0ND4btw0_TigYDxAa9sN6mrUaz9Y4wCZrq3sYLv5ogevpyC8R-v1Eh1daTfeJSZNMNpBOvaogdHbEPUBXduhQb3vLrXfdTGjndshuOk9hAAV6ju3C9qYRntbAbqKR9tCeJE8q7UL8PJ-P0h-HB-dr07Ts68n69WHs9QwyXAqjTYcKKdYyIpDVZu6yhkjsmYGM6ypZoaUeVULUUrOTCVwVRBRC53XpiQZPUjezr6xwl8jhEFtbTDgnG6hG4PKROwppzyu_0AzVgiK2b9RLrNcFgUhEX3zB3rRjb6Nb54oyotCiqnMdzNlfBeCh1r13m5jR1WG1TQHKs6BupuDyL6-dxzLLVSP5MPHR-BwBq6tg93fndTH9fmDZTor4p_CzaNC-0vFBRW5-vnlROFvx99Xnz9lqqC_AasszpU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1693688971</pqid></control><display><type>article</type><title>High throughput screening of particle conditioning operations: II. Evaluation of scale-up heuristics with prokaryotically expressed polysaccharide vaccines</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Noyes, Aaron ; Huffman, Ben ; Berrill, Alex ; Merchant, Nick ; Godavarti, Ranga ; Titchener-Hooker, Nigel ; Coffman, Jonathan ; Sunasara, Khurram ; Mukhopadhyay, Tarit</creator><creatorcontrib>Noyes, Aaron ; Huffman, Ben ; Berrill, Alex ; Merchant, Nick ; Godavarti, Ranga ; Titchener-Hooker, Nigel ; Coffman, Jonathan ; Sunasara, Khurram ; Mukhopadhyay, Tarit</creatorcontrib><description>ABSTRACT
Multivalent polysaccharide conjugate vaccines are typically comprised of several different polysaccharides produced with distinct and complex production processes. Particle conditioning steps, such as precipitation and flocculation, may be used to aid the recovery and purification of such microbial vaccine products. An ultra scale‐down approach to purify vaccine polysaccharides at the micro‐scale would greatly enhance productivity, robustness, and speed the development of novel conjugate vaccines. In part one of this series, we described a modular and high throughput approach to develop particle conditioning processes (HTPC) for biologicals that combines flocculation, solids removal, and streamlined analytics. In this second part of the series, we applied HTPC to industrially relevant feedstreams comprised of capsular polysaccharides (CPS) from several bacterial species. The scalability of HTPC was evaluated between 0.8 mL and 13 L scales, with several different scaling methodologies examined. Clarification, polysaccharide yield, impurity clearance, and product quality achieved with HTPC were reproducible and comparable with larger scales. Particle sizing was the response with greatest sensitivity to differences in processing scale and enabled the identification of useful scaling rules. Scaling with constant impeller tip speed or power per volume in the impeller swept zone offered the most accurate scale up, with evidence that time integration of these values provided the optimal basis for scaling. The capability to develop a process at the micro‐scale combined with evidence‐based scaling metrics provide a significant advance for purification process development of vaccine processes. The USD system offers similar opportunities for HTPC of proteins and other complex biological molecules. Biotechnol. Bioeng. 2015;112: 1568–1582. © 2015 Wiley Periodicals, Inc.
The High Throughput Particle Conditioning tool previously described in Part 1 of this series is tested on several prokaryotic polysaccharide vaccines streams of industrial relevance. The scalability of this method was evaluated between the 800 microliter and the 13 liter scales. Clarification, yield, impurity clearance and product quality were all evaluated as different scaling methods were evaluated to ascertain which provided the best matched results. This work represents a significant advance in high throughput development of vaccine processes.</description><identifier>ISSN: 0006-3592</identifier><identifier>EISSN: 1097-0290</identifier><identifier>DOI: 10.1002/bit.25580</identifier><identifier>PMID: 25727194</identifier><identifier>CODEN: BIBIAU</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Bacteria ; Bacterial Vaccines - genetics ; Bacterial Vaccines - immunology ; Bacterial Vaccines - isolation & purification ; Biological Products - immunology ; Biological Products - isolation & purification ; Bioreactors - microbiology ; capsular polysaccharide ; clarification ; Clearances ; Conditioning ; DOE ; Flocculating ; Flocculation ; Heuristic ; high throughput process development ; Impellers ; Impurities ; MALS ; particle conditioning ; Polysaccharides ; Polysaccharides, Bacterial - genetics ; Polysaccharides, Bacterial - immunology ; Polysaccharides, Bacterial - isolation & purification ; Precipitation ; Prokaryotes ; Proteins ; purity ; QbD ; scalability ; screening ; Technology, Pharmaceutical - methods ; ultra scale-down ; vaccine ; Vaccines ; windows of operation ; yield</subject><ispartof>Biotechnology and bioengineering, 2015-08, Vol.112 (8), p.1568-1582</ispartof><rights>2015 Wiley Periodicals, Inc.</rights><rights>Copyright Wiley Subscription Services, Inc. Aug 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4940-9cac6e363079d6edfcfd54429f4c040a3a4c2b5df77b964cd70d827f7a5fcb213</citedby><cites>FETCH-LOGICAL-c4940-9cac6e363079d6edfcfd54429f4c040a3a4c2b5df77b964cd70d827f7a5fcb213</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fbit.25580$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fbit.25580$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25727194$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Noyes, Aaron</creatorcontrib><creatorcontrib>Huffman, Ben</creatorcontrib><creatorcontrib>Berrill, Alex</creatorcontrib><creatorcontrib>Merchant, Nick</creatorcontrib><creatorcontrib>Godavarti, Ranga</creatorcontrib><creatorcontrib>Titchener-Hooker, Nigel</creatorcontrib><creatorcontrib>Coffman, Jonathan</creatorcontrib><creatorcontrib>Sunasara, Khurram</creatorcontrib><creatorcontrib>Mukhopadhyay, Tarit</creatorcontrib><title>High throughput screening of particle conditioning operations: II. Evaluation of scale-up heuristics with prokaryotically expressed polysaccharide vaccines</title><title>Biotechnology and bioengineering</title><addtitle>Biotechnol. Bioeng</addtitle><description>ABSTRACT
Multivalent polysaccharide conjugate vaccines are typically comprised of several different polysaccharides produced with distinct and complex production processes. Particle conditioning steps, such as precipitation and flocculation, may be used to aid the recovery and purification of such microbial vaccine products. An ultra scale‐down approach to purify vaccine polysaccharides at the micro‐scale would greatly enhance productivity, robustness, and speed the development of novel conjugate vaccines. In part one of this series, we described a modular and high throughput approach to develop particle conditioning processes (HTPC) for biologicals that combines flocculation, solids removal, and streamlined analytics. In this second part of the series, we applied HTPC to industrially relevant feedstreams comprised of capsular polysaccharides (CPS) from several bacterial species. The scalability of HTPC was evaluated between 0.8 mL and 13 L scales, with several different scaling methodologies examined. Clarification, polysaccharide yield, impurity clearance, and product quality achieved with HTPC were reproducible and comparable with larger scales. Particle sizing was the response with greatest sensitivity to differences in processing scale and enabled the identification of useful scaling rules. Scaling with constant impeller tip speed or power per volume in the impeller swept zone offered the most accurate scale up, with evidence that time integration of these values provided the optimal basis for scaling. The capability to develop a process at the micro‐scale combined with evidence‐based scaling metrics provide a significant advance for purification process development of vaccine processes. The USD system offers similar opportunities for HTPC of proteins and other complex biological molecules. Biotechnol. Bioeng. 2015;112: 1568–1582. © 2015 Wiley Periodicals, Inc.
The High Throughput Particle Conditioning tool previously described in Part 1 of this series is tested on several prokaryotic polysaccharide vaccines streams of industrial relevance. The scalability of this method was evaluated between the 800 microliter and the 13 liter scales. Clarification, yield, impurity clearance and product quality were all evaluated as different scaling methods were evaluated to ascertain which provided the best matched results. This work represents a significant advance in high throughput development of vaccine processes.</description><subject>Bacteria</subject><subject>Bacterial Vaccines - genetics</subject><subject>Bacterial Vaccines - immunology</subject><subject>Bacterial Vaccines - isolation & purification</subject><subject>Biological Products - immunology</subject><subject>Biological Products - isolation & purification</subject><subject>Bioreactors - microbiology</subject><subject>capsular polysaccharide</subject><subject>clarification</subject><subject>Clearances</subject><subject>Conditioning</subject><subject>DOE</subject><subject>Flocculating</subject><subject>Flocculation</subject><subject>Heuristic</subject><subject>high throughput process development</subject><subject>Impellers</subject><subject>Impurities</subject><subject>MALS</subject><subject>particle conditioning</subject><subject>Polysaccharides</subject><subject>Polysaccharides, Bacterial - genetics</subject><subject>Polysaccharides, Bacterial - immunology</subject><subject>Polysaccharides, Bacterial - isolation & purification</subject><subject>Precipitation</subject><subject>Prokaryotes</subject><subject>Proteins</subject><subject>purity</subject><subject>QbD</subject><subject>scalability</subject><subject>screening</subject><subject>Technology, Pharmaceutical - methods</subject><subject>ultra scale-down</subject><subject>vaccine</subject><subject>Vaccines</subject><subject>windows of operation</subject><subject>yield</subject><issn>0006-3592</issn><issn>1097-0290</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk1v1DAQhiMEotvCgT-ALHGBQ7aO7dgxN1j6sVL5koo4Wo4z2bj1JsFO2u5v6Z_FadoekBAcLHvGz_tqPJ4keZXhZYYxOSztsCR5XuAnySLDUqSYSPw0WWCMeUpzSfaS_RAuYigKzp8neyQXRGSSLZLbU7tp0ND4btw0_TigYDxAa9sN6mrUaz9Y4wCZrq3sYLv5ogevpyC8R-v1Eh1daTfeJSZNMNpBOvaogdHbEPUBXduhQb3vLrXfdTGjndshuOk9hAAV6ju3C9qYRntbAbqKR9tCeJE8q7UL8PJ-P0h-HB-dr07Ts68n69WHs9QwyXAqjTYcKKdYyIpDVZu6yhkjsmYGM6ypZoaUeVULUUrOTCVwVRBRC53XpiQZPUjezr6xwl8jhEFtbTDgnG6hG4PKROwppzyu_0AzVgiK2b9RLrNcFgUhEX3zB3rRjb6Nb54oyotCiqnMdzNlfBeCh1r13m5jR1WG1TQHKs6BupuDyL6-dxzLLVSP5MPHR-BwBq6tg93fndTH9fmDZTor4p_CzaNC-0vFBRW5-vnlROFvx99Xnz9lqqC_AasszpU</recordid><startdate>201508</startdate><enddate>201508</enddate><creator>Noyes, Aaron</creator><creator>Huffman, Ben</creator><creator>Berrill, Alex</creator><creator>Merchant, Nick</creator><creator>Godavarti, Ranga</creator><creator>Titchener-Hooker, Nigel</creator><creator>Coffman, Jonathan</creator><creator>Sunasara, Khurram</creator><creator>Mukhopadhyay, Tarit</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QF</scope><scope>7QO</scope><scope>7QQ</scope><scope>7SC</scope><scope>7SE</scope><scope>7SP</scope><scope>7SR</scope><scope>7T7</scope><scope>7TA</scope><scope>7TB</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>C1K</scope><scope>F28</scope><scope>FR3</scope><scope>H8D</scope><scope>H8G</scope><scope>JG9</scope><scope>JQ2</scope><scope>KR7</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201508</creationdate><title>High throughput screening of particle conditioning operations: II. Evaluation of scale-up heuristics with prokaryotically expressed polysaccharide vaccines</title><author>Noyes, Aaron ; Huffman, Ben ; Berrill, Alex ; Merchant, Nick ; Godavarti, Ranga ; Titchener-Hooker, Nigel ; Coffman, Jonathan ; Sunasara, Khurram ; Mukhopadhyay, Tarit</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4940-9cac6e363079d6edfcfd54429f4c040a3a4c2b5df77b964cd70d827f7a5fcb213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Bacteria</topic><topic>Bacterial Vaccines - genetics</topic><topic>Bacterial Vaccines - immunology</topic><topic>Bacterial Vaccines - isolation & purification</topic><topic>Biological Products - immunology</topic><topic>Biological Products - isolation & purification</topic><topic>Bioreactors - microbiology</topic><topic>capsular polysaccharide</topic><topic>clarification</topic><topic>Clearances</topic><topic>Conditioning</topic><topic>DOE</topic><topic>Flocculating</topic><topic>Flocculation</topic><topic>Heuristic</topic><topic>high throughput process development</topic><topic>Impellers</topic><topic>Impurities</topic><topic>MALS</topic><topic>particle conditioning</topic><topic>Polysaccharides</topic><topic>Polysaccharides, Bacterial - genetics</topic><topic>Polysaccharides, Bacterial - immunology</topic><topic>Polysaccharides, Bacterial - isolation & purification</topic><topic>Precipitation</topic><topic>Prokaryotes</topic><topic>Proteins</topic><topic>purity</topic><topic>QbD</topic><topic>scalability</topic><topic>screening</topic><topic>Technology, Pharmaceutical - methods</topic><topic>ultra scale-down</topic><topic>vaccine</topic><topic>Vaccines</topic><topic>windows of operation</topic><topic>yield</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Noyes, Aaron</creatorcontrib><creatorcontrib>Huffman, Ben</creatorcontrib><creatorcontrib>Berrill, Alex</creatorcontrib><creatorcontrib>Merchant, Nick</creatorcontrib><creatorcontrib>Godavarti, Ranga</creatorcontrib><creatorcontrib>Titchener-Hooker, Nigel</creatorcontrib><creatorcontrib>Coffman, Jonathan</creatorcontrib><creatorcontrib>Sunasara, Khurram</creatorcontrib><creatorcontrib>Mukhopadhyay, Tarit</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Aluminium Industry Abstracts</collection><collection>Biotechnology Research Abstracts</collection><collection>Ceramic Abstracts</collection><collection>Computer and Information Systems Abstracts</collection><collection>Corrosion Abstracts</collection><collection>Electronics & Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Materials Business File</collection><collection>Mechanical & Transportation Engineering Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ANTE: Abstracts in New Technology & Engineering</collection><collection>Engineering Research Database</collection><collection>Aerospace Database</collection><collection>Copper Technical Reference Library</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>Civil Engineering Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biotechnology and bioengineering</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Noyes, Aaron</au><au>Huffman, Ben</au><au>Berrill, Alex</au><au>Merchant, Nick</au><au>Godavarti, Ranga</au><au>Titchener-Hooker, Nigel</au><au>Coffman, Jonathan</au><au>Sunasara, Khurram</au><au>Mukhopadhyay, Tarit</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High throughput screening of particle conditioning operations: II. Evaluation of scale-up heuristics with prokaryotically expressed polysaccharide vaccines</atitle><jtitle>Biotechnology and bioengineering</jtitle><addtitle>Biotechnol. Bioeng</addtitle><date>2015-08</date><risdate>2015</risdate><volume>112</volume><issue>8</issue><spage>1568</spage><epage>1582</epage><pages>1568-1582</pages><issn>0006-3592</issn><eissn>1097-0290</eissn><coden>BIBIAU</coden><abstract>ABSTRACT
Multivalent polysaccharide conjugate vaccines are typically comprised of several different polysaccharides produced with distinct and complex production processes. Particle conditioning steps, such as precipitation and flocculation, may be used to aid the recovery and purification of such microbial vaccine products. An ultra scale‐down approach to purify vaccine polysaccharides at the micro‐scale would greatly enhance productivity, robustness, and speed the development of novel conjugate vaccines. In part one of this series, we described a modular and high throughput approach to develop particle conditioning processes (HTPC) for biologicals that combines flocculation, solids removal, and streamlined analytics. In this second part of the series, we applied HTPC to industrially relevant feedstreams comprised of capsular polysaccharides (CPS) from several bacterial species. The scalability of HTPC was evaluated between 0.8 mL and 13 L scales, with several different scaling methodologies examined. Clarification, polysaccharide yield, impurity clearance, and product quality achieved with HTPC were reproducible and comparable with larger scales. Particle sizing was the response with greatest sensitivity to differences in processing scale and enabled the identification of useful scaling rules. Scaling with constant impeller tip speed or power per volume in the impeller swept zone offered the most accurate scale up, with evidence that time integration of these values provided the optimal basis for scaling. The capability to develop a process at the micro‐scale combined with evidence‐based scaling metrics provide a significant advance for purification process development of vaccine processes. The USD system offers similar opportunities for HTPC of proteins and other complex biological molecules. Biotechnol. Bioeng. 2015;112: 1568–1582. © 2015 Wiley Periodicals, Inc.
The High Throughput Particle Conditioning tool previously described in Part 1 of this series is tested on several prokaryotic polysaccharide vaccines streams of industrial relevance. The scalability of this method was evaluated between the 800 microliter and the 13 liter scales. Clarification, yield, impurity clearance and product quality were all evaluated as different scaling methods were evaluated to ascertain which provided the best matched results. This work represents a significant advance in high throughput development of vaccine processes.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>25727194</pmid><doi>10.1002/bit.25580</doi><tpages>15</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-3592 |
ispartof | Biotechnology and bioengineering, 2015-08, Vol.112 (8), p.1568-1582 |
issn | 0006-3592 1097-0290 |
language | eng |
recordid | cdi_proquest_miscellaneous_1709763676 |
source | MEDLINE; Access via Wiley Online Library |
subjects | Bacteria Bacterial Vaccines - genetics Bacterial Vaccines - immunology Bacterial Vaccines - isolation & purification Biological Products - immunology Biological Products - isolation & purification Bioreactors - microbiology capsular polysaccharide clarification Clearances Conditioning DOE Flocculating Flocculation Heuristic high throughput process development Impellers Impurities MALS particle conditioning Polysaccharides Polysaccharides, Bacterial - genetics Polysaccharides, Bacterial - immunology Polysaccharides, Bacterial - isolation & purification Precipitation Prokaryotes Proteins purity QbD scalability screening Technology, Pharmaceutical - methods ultra scale-down vaccine Vaccines windows of operation yield |
title | High throughput screening of particle conditioning operations: II. Evaluation of scale-up heuristics with prokaryotically expressed polysaccharide vaccines |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T11%3A29%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20throughput%20screening%20of%20particle%20conditioning%20operations:%20II.%20Evaluation%20of%20scale-up%20heuristics%20with%20prokaryotically%20expressed%20polysaccharide%20vaccines&rft.jtitle=Biotechnology%20and%20bioengineering&rft.au=Noyes,%20Aaron&rft.date=2015-08&rft.volume=112&rft.issue=8&rft.spage=1568&rft.epage=1582&rft.pages=1568-1582&rft.issn=0006-3592&rft.eissn=1097-0290&rft.coden=BIBIAU&rft_id=info:doi/10.1002/bit.25580&rft_dat=%3Cproquest_cross%3E3735117111%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1693688971&rft_id=info:pmid/25727194&rfr_iscdi=true |